DPM & IBS
- Share
- Share on Facebook
- Share on X
- Share on LinkedIn
This work identifies a novel antibacterial mechanism that targets the cell wall of the human pathogen Streptococcus pneumoniae. Unlike conventional cell-wall targeting antibiotics, which inhibit the natural cross-linking of peptidoglycan, we introduce artificial cross-links using metabolic engineering to insert a clickable function into the other main component of the Gram-positive cell wall, the teichoic acids, then perform Strain-Promoted Alkyne-Azide Cycloaddition (SPAAC) and demonstrate that this results in impaired cell growth.
“Cross-linking teichoic acids by click chemistry prevents bacterial cell growth”M. Baudoin, A. Chouquet, C. Boyat, C. Laguri, A. Zapun, B. Pérès, C. Morlot, Y.-S. Wong, C. Durmort, Chem. Commun., 2025, 61, 9940–9943. https://doi.org/10.1039/D5CC02577J
- Share
- Share on Facebook
- Share on X
- Share on LinkedIn